Efficacy and safety of quadruple therapy including tirofiban in the treatment of Chinese NSTE-ACS patients failing to receive timely percutaneous coronary intervention

BACKGROUND: Although it has been shown to be superior to simple antithrombotic drug therapy, most patients are unable to receive timely percutaneous coronary intervention (PCI) and are treated with conventional triple antithrombotic therapy (aspirin, clopidogrel, low-molecular-weight heparin). Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lan, Ge, Zhenrong, Zhang, Dengke, Kuang, Jun, Ma, Xiang, Jiang, Shubin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701602/
https://www.ncbi.nlm.nih.gov/pubmed/29200825
http://dx.doi.org/10.2147/DDDT.S138714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701602/
https://www.ncbi.nlm.nih.gov/pubmed/29200825
http://dx.doi.org/10.2147/DDDT.S138714

Ejemplares similares